Literature DB >> 15955592

Stromal cell-derived factor-1 (SDF-1) gene and susceptibility of Iranian patients with lung cancer.

Mahboobeh Razmkhah1, Mehrnoosh Doroudchi, S M A Ghayumi, Nasrollah Erfani, Abbas Ghaderi.   

Abstract

Stromal cell derived factor-1 (SDF-1), a CXC chemokine that play important roles in tumor growth, angiogenesis and metastasis of tumor cells, has a polymorphism at position 801 of its 3'-untranslated region, known as SDF1-3'A. This polymorphism has been investigated in HIV-1 infection and the susceptibility to breast cancer. In this investigation 72 lung cancer patients and 262 cases of normal healthy control were investigated for the genotype frequency of SDF-1 gene. Genotype frequency was carried out by PCR-RFLP method. Of 72 cancer patients 9 (12.5%) cases were emerged with AA genotype, 38 (52.8%) patients with AG and 25 (34.7%) with GG genotype. Comparison of these data with genotype frequency of SDF-1 gene of 262 normal healthy controls indicates a significant difference among patient and control groups (P=0.008). Results also showed that the frequency of AA and AG genotypes was higher among patients, while the frequency of GG genotype was lower compared to the controls. By considering the importance of SDF-1 in several physiological processes and also its significant biological behavior in cancer metastasis and on the basis of the results of this study we conclude that AA and AG genotypes of SDF-1 may be considered as factors increasing the susceptibility of Iranian patients to lung cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15955592     DOI: 10.1016/j.lungcan.2005.04.014

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  25 in total

1.  The role of polymorphisms of genes CXCL12/CXCR4 and MIF in the risk development IBD the Polish population.

Authors:  Jerzy Mrowicki; Karolina Przybylowska-Sygut; Lukasz Dziki; Andrzej Sygut; Jan Chojnacki; Adam Dziki; Ireneusz Majsterek
Journal:  Mol Biol Rep       Date:  2014-04-01       Impact factor: 2.316

2.  CXCL12 G801A polymorphism and cancer risk: An updated meta-analysis.

Authors:  Dan Meng; Yin-Xiang Wu; Vidhi Heerah; Shuang Peng; Meng-di Chu; Yong-Jian Xu; Wei-Ning Xiong; Shu-Yun Xu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-06-14

3.  Association between SDF1-3'A or CXCR4 gene polymorphisms with predisposition to and clinicopathological characteristics of prostate cancer with or without metastases.

Authors:  Ferruh K Işman; Canan Kucukgergin; Selçuk Daşdemir; Bedia Cakmakoglu; Oner Sanli; Sule Seckin
Journal:  Mol Biol Rep       Date:  2012-10-11       Impact factor: 2.316

4.  Genetic variants of SDF-1 and CXCR4 genes in endometrial carcinoma.

Authors:  Canan Cacina; Sibel Bulgurcuoglu-Kuran; Ahmet Cem Iyibozkurt; Ilhan Yaylim-Eraltan; Bedia Cakmakoglu
Journal:  Mol Biol Rep       Date:  2011-05-24       Impact factor: 2.316

5.  SDF-1 and CCR5 genes polymorphism in patients with head and neck cancer.

Authors:  Bijan Khademi; Mahboobeh Razmkhah; Nasrollah Erfani; Marjan Gharagozloo; Abbas Ghaderi
Journal:  Pathol Oncol Res       Date:  2008-04-02       Impact factor: 3.201

6.  SDF-1alpha G801A polymorphism in Southern Iranian patients with colorectal and gastric cancers.

Authors:  Mahboobeh Razmkhah; Abbas Ghaderi
Journal:  Indian J Gastroenterol       Date:  2012-12-16

7.  SDF1-3' a gene polymorphism is associated with laryngeal cancer.

Authors:  Lukasz Kruszyna; Margarita Lianeri; Małgorzata Rydzanicz; Krzysztof Szyfter; Paweł P Jagodziński
Journal:  Pathol Oncol Res       Date:  2009-10-16       Impact factor: 3.201

8.  Genetic variation in CXCL12 and risk of cervical carcinoma: a population-based case-control study.

Authors:  S N Maley; S M Schwartz; L G Johnson; M Malkki; Q Du; J R Daling; S S Li; L P Zhao; E W Petersdorf; M M Madeleine
Journal:  Int J Immunogenet       Date:  2009-09-24       Impact factor: 1.466

9.  CXCL12 rs1801157 polymorphism in patients with breast cancer, Hodgkin's lymphoma, and non-Hodgkin's lymphoma.

Authors:  Karen Brajão de Oliveira; Julie Massayo Maeda Oda; Julio Cesar Voltarelli; Thiago Franco Nasser; Mario Augusto Ono; Thiago Cezar Fujita; Tiemi Matsuo; Maria Angelica Ehara Watanabe
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

10.  Analysis of the expression of SDF-1 splicing variants in human colorectal cancer and normal mucosa tissues.

Authors:  Risala Hussain Allami; Claudine Graf; Ksenia Martchenko; Beatrice Voss; Marc Becker; Martin R Berger; Peter R Galle; Matthias Theobald; Thomas C Wehler; Carl C Schimanski
Journal:  Oncol Lett       Date:  2016-01-25       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.